Biosolution Co.Ltd (086820) - Total Liabilities

Latest as of September 2025: ₩36.25 Billion KRW ≈ $24.56 Million USD

Based on the latest financial reports, Biosolution Co.Ltd (086820) has total liabilities worth ₩36.25 Billion KRW (≈ $24.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Biosolution Co.Ltd growing its equity to track the company's year-over-year net asset growth rate.

Biosolution Co.Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how Biosolution Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Biosolution Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.

Biosolution Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Biosolution Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hwashin Precision Engineering Co. Ltd KQ:126640	Korea	₩108.61 Billion
Mahachai Hospital Public Company Limited BK:M-CHAI	Thailand	฿7.80 Billion
Catur Sentosa Adiprana Tbk JK:CSAP	Indonesia	Rp8.24 Trillion
Yoosung T&S Co. Ltd KQ:024800	Korea	₩99.40 Billion
CI Holdings Bhd KLSE:2828	Malaysia	RM929.83 Million
Midnight Sun Mining Corp V:MMA	Canada	CA$678.98K
HLS Therapeutics Inc TO:HLS	Canada	CA$75.72 Million
Big River Industries Ltd AU:BRI	Australia	AU$145.90 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Biosolution Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Biosolution Co.Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.38	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biosolution Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biosolution Co.Ltd (2015–2024)

The table below shows the annual total liabilities of Biosolution Co.Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩36.21 Billion ≈ $24.54 Million	-27.90%
2023-12-31	₩50.22 Billion ≈ $34.03 Million	+4.72%
2022-12-31	₩47.96 Billion ≈ $32.50 Million	-2.91%
2021-12-31	₩49.39 Billion ≈ $33.47 Million	+1475.96%
2020-12-31	₩3.13 Billion ≈ $2.12 Million	-15.54%
2019-12-31	₩3.71 Billion ≈ $2.51 Million	-2.39%
2018-12-31	₩3.80 Billion ≈ $2.58 Million	+28.41%
2017-12-31	₩2.96 Billion ≈ $2.01 Million	+9.73%
2016-12-31	₩2.70 Billion ≈ $1.83 Million	+12.64%
2015-12-31	₩2.40 Billion ≈ $1.62 Million	--

About Biosolution Co.Ltd

KQ:086820 Korea Biotechnology

Market Cap

$95.18 Million

₩140.44 Billion KRW

Market Cap Rank

#19322 Global

#931 in Korea

Share Price

₩5820.00

Change (1 day)

-0.17%

52-Week Range

₩5510.00 - ₩12950.00

All Time High

₩62300.00